UNSPSC 51385501: Ethenzamide

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L929ZCK4BF. European Medicines Agency schedules Ethenzamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07274MIG. Ethenzamide generally arises in the molecular formula C9H11NO2.

UNSPSC 51385501 Ethenzamide (Commodity) does not map to the state and local opportunities recently posted under this code. The three recent solicitations—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's RFI on direct-to-manufacturer prescriptions, and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products—concern naloxone distribution, pharmacy benefit program design, and wholesale pharmaceutical supply respectively. None of these opportunities directly involve ethenzamide, an analgesic agent. The code shows little relevant recent activity, and the mismatch between the code's nominal scope and the work actually being solicited suggests either tagging error or that ethenzamide procurement through state and local channels does not currently appear in recent competitive notices.

No recent opportunities directly soliciting ethenzamide under this Commodity code are present in the source material. Firms evaluating pursuit should verify whether state and local demand for ethenzamide as a discrete procurement item exists through direct agency outreach or cooperative-purchasing vehicle catalogs, as it may not generate standalone RFPs or RFQs at present.